Lipid Labs

Lipid Lab is a South Korean biotechnology company specializing in the development of advanced lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics. The company's proprietary LNP-X platform focuses on synthesizing novel ionizable lipids to overcome the limitations of current delivery technologies, such as liver-restricted accumulation and systemic toxicity. By enabling extrahepatic targeting, Lipid Lab aims to deliver mRNA, siRNA, and gene-editing tools to specific tissues including the lungs, spleen, and brain. The company is building an internal pipeline of mRNA vaccines and oncology treatments while actively collaborating with pharmaceutical partners to integrate its delivery technology into diverse therapeutic programs.